APOB and metabolic syndrome: Dyslipidemia is as a major risk factor for CVDs, being in general characterized by an elevated fasting and postprandial concentration of total triglycerides (TG) and of free fatty acids, in combination with the preponderance of low-density lipoproteins cholesterol (LDL-C) along with low levels of high-density lipoproteins cholesterol (HDL-C) and of apolipoprotein B (apo B) plasmatic concentrations [5].